APAIIF 亞太人工智能產業總會APAIIFAI Knowledge

AI in Healthcare

Discover AI applications and innovations in healthcare

65 articles

Scan.com Raises $220M: AI Agentic Infrastructure Automates Medical Imaging Scheduling, $165M ARR Achieved, IPO Path Explored

Scan.com Raises $220M: AI Agentic Infrastructure Automates Medical Imaging Scheduling, $165M ARR Achieved, IPO Path Explored

Scan.com completed $220M in financing on August 31, 2026, including a $90M Series C equity round led by Noteus Partners and $130M in debt facilities. The company surpassed $165M ARR with revenue doubling over the past year. Its AI agentic infrastructure automates patient routing, scan scheduling, and diagnostic result delivery, having served over 900,000 patients, while exploring a potential London Stock Exchange listing.

Sep 12, 202611
Vitestro Aletta Receives FDA De Novo Authorization: First Autonomous Robotic Blood Draw Device, 94.5% First-Stick Success Rate, Addressing Global Phlebotomist Shortage

Vitestro Aletta Receives FDA De Novo Authorization: First Autonomous Robotic Blood Draw Device, 94.5% First-Stick Success Rate, Addressing Global Phlebotomist Shortage

Vitestro's Aletta autonomous robotic blood draw device received FDA De Novo authorization on August 19, 2026, becoming the world's first approved standalone robotic blood draw system. Clinical trials showed a 94.5% first-stick success rate, with 90% of patients reporting pain comparable to or less than manual draws, potentially alleviating the global phlebotomist shortage crisis.

Sep 11, 202611
FDA TEMPO Pilot Program Officially Launched: New Regulatory Framework for Generative AI Medical Devices, Four Companies Including Cadence and Limbic Selected, Creating 'Limited Early Market Path'

FDA TEMPO Pilot Program Officially Launched: New Regulatory Framework for Generative AI Medical Devices, Four Companies Including Cadence and Limbic Selected, Creating 'Limited Early Market Path'

The FDA officially launched the TEMPO pilot program, allowing generative AI medical devices from four companies—Cadence, Limbic, SonderMind, and Dexcom—to enter the market without formal authorization, while releasing a two-axis risk assessment framework that creates a new model for AI medical device regulation.

Sep 10, 202610
MIRA Medical AI Agent Published in Nature: 88.9% Diagnostic Accuracy in Autonomous EHR Clinical Workflows, 500+ Emergency Cases Validated at Physician Level

MIRA Medical AI Agent Published in Nature: 88.9% Diagnostic Accuracy in Autonomous EHR Clinical Workflows, 500+ Emergency Cases Validated at Physician Level

Nature published MIRA (Medical Intelligence for Reasoning and Action) in June 2026, achieving 88.9% diagnostic accuracy across 500+ emergency cases, autonomously navigating 85,000+ EHR actions including ordering tests, interpreting imaging, and formulating treatment plans at or above physician level.

Sep 9, 202610
Eli Lilly × Insilico Medicine $2.75B AI Drug Discovery Deal: Generative AI Accelerates Oral Therapeutics Pipeline

Eli Lilly × Insilico Medicine $2.75B AI Drug Discovery Deal: Generative AI Accelerates Oral Therapeutics Pipeline

In March 2026, Eli Lilly and Insilico Medicine signed a research and licensing collaboration valued at up to $2.75 billion, including $115 million upfront and approximately $2.63 billion in milestone payments. Insilico's Pharma.AI platform integrates generative AI for target identification and molecular design, dramatically compressing early drug discovery timelines. This is one of the largest AI drug discovery deals in pharmaceutical history.

Sep 8, 20269
AI Brain Hemorrhage Detection Breakthrough: CNN-Bi-LSTM Hybrid Framework Achieves 93.36% Accuracy, ROC-AUC 98.34%, Emergency Radiology Decision Support Enters New Era

AI Brain Hemorrhage Detection Breakthrough: CNN-Bi-LSTM Hybrid Framework Achieves 93.36% Accuracy, ROC-AUC 98.34%, Emergency Radiology Decision Support Enters New Era

Latest 2026 research shows a hybrid deep learning framework combining CNN and Bi-LSTM achieves 93.36% accuracy and 98.34% ROC-AUC in brain hemorrhage CT scan detection. AI systems can identify life-threatening brain hemorrhages in seconds, significantly reducing emergency radiology interpretation time, though widespread clinical adoption still faces model interpretability and external validation challenges.

Sep 7, 20269
Assort Health Closes $120M Series C: Synapse AI Model Trained on 190M Patient Interactions, Revenue Grows 20x in 15 Months

Assort Health Closes $120M Series C: Synapse AI Model Trained on 190M Patient Interactions, Revenue Grows 20x in 15 Months

Assort Health closes $120M Series C at $1.2B valuation, achieving unicorn status. Synapse AI model trained on 190M patient interactions and 62,000 care protocols delivers 20x revenue growth in 15 months. Four AI agent products automate patient scheduling, referrals, and administrative workflows, led by Menlo Ventures.

Sep 5, 20268
Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax

Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax

Scan.com closes $220M in combined equity and debt financing with annualized revenue exceeding $165M. The company uses AI agent technology to revolutionize medical imaging scheduling, addressing the U.S. market where 85% of scans are still booked by fax, having served over 900,000 patients globally.

Sep 3, 202612
FedEHR-Agents and CareGraph: Federated Learning AI Agents Revolutionize Clinical EHR Modeling, Enabling Cross-Hospital Knowledge Sharing While Protecting Patient Privacy

FedEHR-Agents and CareGraph: Federated Learning AI Agents Revolutionize Clinical EHR Modeling, Enabling Cross-Hospital Knowledge Sharing While Protecting Patient Privacy

FedEHR-Agents replaces model parameters with 'clinical modeling experience' as the federated learning collaborative object, enabling cross-hospital knowledge sharing while strictly protecting patient data; CareGraph provides auditable hybrid AI health intelligence, avoiding overly autonomous clinical decision-making.

Sep 2, 202612
Chai Discovery Closes $400M Series C: Chai-3 Doubles Antibody Design Success Rate, Eli Lilly, Pfizer, and Novartis Back AI Drug Discovery Star

Chai Discovery Closes $400M Series C: Chai-3 Doubles Antibody Design Success Rate, Eli Lilly, Pfizer, and Novartis Back AI Drug Discovery Star

Chai Discovery closed a $400M Series C in July 2026, reaching a $3.8B valuation. The Chai-3 model doubles antibody design success rates with two-week validation cycles, securing strategic partnerships with Eli Lilly, Pfizer, and Novartis, signaling AI drug discovery's commercial maturity.

Sep 1, 202612
Pew Research Survey: 72% of Americans Demand Mandatory Healthcare AI Disclosure, Public Trust Drops from 52% to 42%, Healthcare AI Faces Transparency Crisis

Pew Research Survey: 72% of Americans Demand Mandatory Healthcare AI Disclosure, Public Trust Drops from 52% to 42%, Healthcare AI Faces Transparency Crisis

Pew Research Center published a new survey on August 25, 2026, showing 72% of American adults believe healthcare providers must mandatorily disclose AI use, with over 80% wanting notification when AI analyzes medical scans or makes diagnoses. Meanwhile, public acceptance of healthcare AI dropped from 52% in 2024 to 42% in April 2026, with 53% of respondents saying they have little to no say in AI's use in their care.

Aug 31, 202612
Shocking Healthcare Finding: Only 3 of 1,357 FDA-Cleared AI Medical Devices Tested Patient Outcomes, PLOS Digital Health Study Reveals Regulatory Gap

Shocking Healthcare Finding: Only 3 of 1,357 FDA-Cleared AI Medical Devices Tested Patient Outcomes, PLOS Digital Health Study Reveals Regulatory Gap

A study published in PLOS Digital Health in August 2026 reveals that of 1,357 FDA-authorized AI medical devices, only 3 (0.2%) evaluated patient health outcomes and only 34 (2.5%) were linked to prospective clinical trials, exposing a massive gap between regulatory approval and clinical validation that has alarmed the healthcare community.

Aug 30, 202612
PreviousPage 5 / 6Next